================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 10-Q/A
(Amendment No. 1)
(Mark One)
|X| Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
For the Quarter Ended September 30, 2006
OR
|_| Transition Report Pursuant To Section 13 Or 15(d) Of the Securities
Exchange Act of 1934
For the Transition Period from ___________ to _____________
Commission File No. 0-23047
----------
SIGA Technologies, Inc.
(Exact name of registrant as specified in its charter)
A Delaware Corporation IRS Employer No. 13-3864870
420 Lexington Avenue, Suite 408, New York, NY 10170
Telephone Number (212) 672-9100
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes |X| No |_|.
Indicate by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a non-accelerated filer. See definition of "accelerated
filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check
one):
Large Accelerated Filer |_| Accelerated Filer |_| Non-Accelerated Filer |X|.
Indicate by check mark whether the registrant is a shell company (as defined in
rule 12b-2 of the Exchange Act). Yes |_| No |X|.
As of October 31, 2006 the registrant had 31,765,621 shares of common stock
outstanding.
================================================================================
EXPLANATORY NOTE
This Amendment No. 1 on Form 10-Q/A (this "Amendment") amends the
Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2006
filed on November 1, 2006 (the "Original Filing"). We have filed this Amendment
solely to include the information required by Part II, Item 6 - Exhibits. This
information was inadvertently omitted from the Original Filing. In addition, in
connection with the filing of this Amendment and pursuant to the rules of the
Securities and Exchange Commission, we are including with this Amendment certain
currently dated certifications.
Except as described above, no other changes have been made to the Original
Filing. This Amendment has not resulted in any changes to our previously
reported financial results. This Amendment continues to speak as of the date of
the Original Filing, and we have not updated the disclosures contained in this
Amendment to reflect any events that occurred at a date subsequent to the
Original Filing.
1
Part II
Other information
Item 6. Exhibits
* 10.1 Contract, dated September 29, 2006, between SIGA Technologies, Inc.
and the National Institute of Allergy and Infectious Diseases of the
National Institutes for Health.
* 31 Certification of Chief Financial Officer and Acting Chief Executive
Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
* 32 Certification of Chief Financial Officer and Acting Chief Executive
Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
* Filed herein
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
SIGA Technologies, Inc.
(Registrant)
Date: November 13, 2006 By: /s/ Thomas N. Konatich
------------------------
Thomas N. Konatich
Chief Financial Officer and
Acting Chief Executive Officer
3